文献速递炎症性肠病

NTPDase8通过限制P2Y6受体激活保护小鼠肠道炎症

NTPDase8 protects mice from intestinal inflammation by limiting P2Y6 receptor activation: identification of a new pathway of inflammation for the potential treatment of IBD.
PubMed 文献 · Gut · 2021-01-15

该研究利用Entpd8基因敲除小鼠在DSS结肠炎模型中探索NTPDase8的作用,发现其缺失加重组织损伤、免疫细胞浸润、凋亡及促炎因子表达,而阻断P2Y6受体或重建WT骨髓可保护小鼠,提示NTPDase8-P2Y6通路或为IBD治疗新靶点。

要点

  • NTPDase8是结肠腔内水解核苷酸的主要酶,其缺失加重DSS结肠炎。
  • P2Y6是结肠上皮主要表达的P2Y受体,阻断P2Y6可剂量依赖性保护小鼠。
  • 人肠上皮细胞同样表达NTPDase8与P2Y6,提示结果可能可转化。

核心结论

  • NTPDase8最可能通过限制结肠上皮细胞P2Y6受体激活来保护肠道免受炎症,可能为炎症性肠病提供新的治疗策略。

研究设计与样本

  • 生成NTPDase8缺陷(Entpd8-/-)小鼠,在葡聚糖硫酸钠(DSS)结肠炎模型中定义NTPDase8的作用。
  • 结肠组织采用组织病理学、逆转录定量实时PCR(RT-qPCR)和免疫组化分析。
  • 原代肠上皮用RT-qPCR分析P2受体表达,组织化学分析NTPDase8活性。
  • 通过骨髓移植实验和P2Y6受体拮抗剂评估肠道P2Y6受体的作用。

主要发现

  • NTPDase8是负责结肠腔内核苷酸水解的主要酶。
  • 与野生型对照小鼠相比,DSS处理的Entpd8-/-小鼠结肠显示显著更多的组织学损伤、免疫细胞浸润、凋亡及多种促炎细胞因子表达增加。
  • P2Y6是结肠上皮mRNA水平表达的主要P2Y受体。
  • 接受WT骨髓移植的受照射P2ry6-/-小鼠完全免受DSS诱导的肠道炎症。
  • 每日直肠内注射P2Y6拮抗剂以剂量依赖方式保护小鼠免受DSS诱导的肠道炎症。

临床怎么用

  • 动物实验提示靶向NTPDase8-P2Y6轴可能成为IBD治疗策略,尚需人体研究验证。
  • P2Y6拮抗剂在DSS模型中呈剂量依赖性保护作用,支持其作为候选干预方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Nucleotides are danger signals that activate inflammatory responses via binding P2 receptors. The nucleoside triphosphate diphosphohydrolase-8 (NTPDase8) is an ectonucleotidase that hydrolyses P2 receptor ligands. We investigated the role of NTPDase8 in intestinal inflammation. DESIGN: We generated NTPDase8-deficient (Entpd8-/-) mice to define the role of NTPDase8 in the dextran sodium sulfate (DSS) colitis model. To assess inflammation, colons were collected and analysed by histopathology, reverse transcriptase-quantitative real-time PCR (RT-qPCR) and immunohistochemistry. P2 receptor expression was analysed by RT-qPCR on primary intestinal epithelium and NTPDase8 activity by histochemistry. The role of intestinal P2Y6 receptors was assessed by bone marrow transplantation experiments and with a P2Y6 receptor antagonist. RESULTS: NTPDase8 is the dominant enzyme responsible for the hydrolysis of nucleotides in the lumen of the colon. Compared with wild-type (WT) control mice, the colon of Entpd8-/- mice treated with DSS displayed significantly more histological damage, immune cell infiltration, apoptosis and increased expression of several proinflammatory cytokines. P2Y6 was the dominant P2Y receptor expressed at the mRNA level by the colonic epithelia. Irradiated P2ry6-/- mice transplanted with WT bone marrow were fully protected from DSS-induced intestinal inflammation. In agreement, the daily intrarectal injection of a P2Y6 antagonist protected mice from DSS-induced intestinal inflammation in a dose-dependent manner. Finally, human intestinal epithelial cells express NTPDase8 and P2Y6 similarly as in mice. CONCLUSION: NTPDase8 protects the intestine from inflammation most probably by limiting the activation of P2Y6 receptors in colonic epithelial cells. This may provide a novel therapeutic strategy for the treatment of inflammatory bowel disease.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Salem M, Lecka J, Pelletier J, et al. NTPDase8 protects mice from intestinal inflammation by limiting P2Y6 receptor activation: identification of a new pathway of inflammation for the potential treatment of IBD. Gut. 2021. PMID: 33452178. doi:10.1136/gutjnl-2020-320937

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。